Literature DB >> 16413070

Cell internalization and traffic pathway of Clostridium botulinum type C neurotoxin in HT-29 cells.

Nobuo Uotsu1, Atsushi Nishikawa, Toshihiro Watanabe, Tohru Ohyama, Takashi Tonozuka, Yoshiyuki Sakano, Keiji Oguma.   

Abstract

The bacterium Clostridium botulinum type C produces a progenitor toxin (C16S toxin) that binds to O-linked sugar chains terminating with sialic acid on the surface of HT-29 cells prior to internalization [A. Nishikawa, N. Uotsu, H. Arimitsu, J.C. Lee, Y. Miura, Y. Fujinaga, H. Nakada, T. Watanabe, T. Ohyama, Y. Sakano, K. Oguma, Biochem. Biophys. Res. Commun. 319 (2004) 327-333] [21]. Based on this, it was hypothesized that the C16S toxin is internalized via clathrin-coated pits. To examine this possibility, the internalized toxin was observed with a fluorescent antibody using confocal laser-scanning microscopy. The confocal images clearly indicated that the C16S toxin was internalized mainly via clathrin-coated pits and localized in early endosomes. The toxin was colocalized with caveolin-1 which is one of the components of caveolae, however, implying the toxin was also internalized via caveolae. The confocal images also showed that the neurotoxin transported to the endosome was transferred to the Golgi apparatus. However, the non-toxic components were not merged with the Golgi marker protein, TGN38, implying the neurotoxin was dissociated from progenitor toxin in endosomes. These results suggested that the C16S toxin was separated to the neurotoxin and other proteins in endosome and the neurotoxin was further transferred to the Golgi apparatus which is the center for protein sorting.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16413070     DOI: 10.1016/j.bbamcr.2005.11.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  The botulinum toxin complex meets E-cadherin on the way to its destination.

Authors:  Yo Sugawara; Yukako Fujinaga
Journal:  Cell Adh Migr       Date:  2011-01-01       Impact factor: 3.405

2.  Crystal structure of Clostridium botulinum whole hemagglutinin reveals a huge triskelion-shaped molecular complex.

Authors:  Sho Amatsu; Yo Sugawara; Takuhiro Matsumura; Kengo Kitadokoro; Yukako Fujinaga
Journal:  J Biol Chem       Date:  2013-10-28       Impact factor: 5.157

3.  Purification, crystallization and preliminary X-ray analysis of an HA17-HA70 (HA2-HA3) complex from Clostridium botulinum type C progenitor toxin.

Authors:  Chikako Iwasa; Takashi Tonozuka; Masaya Shinoda; Yoshimasa Sagane; Koichi Niwa; Toshihiro Watanabe; Hiromi Yoshida; Shigehiro Kamitori; Toshifumi Takao; Keiji Oguma; Atsushi Nishikawa
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2013-12-24       Impact factor: 1.056

Review 4.  Interaction of botulinum toxin with the epithelial barrier.

Authors:  Yukako Fujinaga
Journal:  J Biomed Biotechnol       Date:  2010-02-14

5.  Molecular assembly of botulinum neurotoxin progenitor complexes.

Authors:  Desirée A Benefield; Scott K Dessain; Nancy Shine; Melanie D Ohi; D Borden Lacy
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

6.  Preferential entry of botulinum neurotoxin A Hc domain through intestinal crypt cells and targeting to cholinergic neurons of the mouse intestine.

Authors:  Aurélie Couesnon; Jordi Molgó; Chloé Connan; Michel R Popoff
Journal:  PLoS Pathog       Date:  2012-03-15       Impact factor: 6.823

7.  Glycan detecting tools developed from the Clostridium botulinum whole hemagglutinin complex.

Authors:  Ea Kristine Clarisse Tulin; Chiaki Nakazawa; Tomomi Nakamura; Shion Saito; Naoki Ohzono; Keiko Hiemori; Shin-Ichi Nakakita; Hiroaki Tateno; Takashi Tonozuka; Atsushi Nishikawa
Journal:  Sci Rep       Date:  2021-11-09       Impact factor: 4.379

8.  Botulinum neurotoxin A complex recognizes host carbohydrates through its hemagglutinin component.

Authors:  Guorui Yao; Kwangkook Lee; Shenyan Gu; Kwok-Ho Lam; Rongsheng Jin
Journal:  Toxins (Basel)       Date:  2014-02-12       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.